Search Results - "Pulford, K."
-
1
Anaplastic lymphoma kinase proteins in growth control and cancer
Published in Journal of cellular physiology (01-06-2004)“…The normal functions of full‐length anaplastic lymphoma kinase (ALK) remain to be completely elucidated. Although considered to be important in neural…”
Get full text
Journal Article -
2
Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis
Published in Leukemia (01-02-2013)“…We studied the prognostic value of minimal disseminated disease (MDD) and anti-ALK immune response in children with NPM-ALK-positive anaplastic-large cell…”
Get full text
Journal Article -
3
CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features
Published in Blood (01-12-2000)“…Anaplastic large cell lymphoma (ALCL) represents a generally recognized group of large cell lymphomas. Defining features consist of a proliferation of…”
Get full text
Journal Article -
4
The emerging normal and disease-related roles of anaplastic lymphoma kinase
Published in Cellular and molecular life sciences : CMLS (01-12-2004)“…Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase, the normal role of which remains to be completely elucidated. Although work carried out in…”
Get full text
Journal Article -
5
Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients
Published in Leukemia (01-02-2014)“…We previously identified autoantibodies to the endocytic-associated protein Huntingtin-interacting protein 1-related (HIP1R) in diffuse large B-cell lymphoma…”
Get full text
Journal Article -
6
Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL
Published in Leukemia (01-02-2009)Get full text
Journal Article -
7
Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation
Published in The American journal of pathology (01-08-1990)“…It has been reported previously that the bcl-2 protooncogene protein is detectable in neoplastic cells from cases of human lymphoma in which the 14;18…”
Get full text
Journal Article -
8
DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma
Published in Leukemia (01-11-2010)“…We previously described PASD1 as a new cancer testis antigen in multiple myeloma (MM) that is retained post-therapy, suggesting the use of vaccination…”
Get full text
Journal Article -
9
Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11AXL protein are frequent in primary mediastinal B-cell lymphoma
Published in Leukemia (01-10-2006)Get full text
Journal Article -
10
Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma
Published in Leukemia (01-10-2006)Get full text
Journal Article -
11
FMIP controls the adipocyte lineage commitment of C2C12 cells by downmodulation of C EBPalpha
Published in Oncogene (15-02-2007)“…Fms interacting protein (FMIP) is a substrate for Fms tyrosine kinase, and a nuclear/cytoplasm shuttling protein with a leucine zipper. As the phosphorylation…”
Get full text
Journal Article -
12
Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis
Published in Molecular and Cellular Biology (01-04-1997)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
13
Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large b-cell lymphoma patients
Published in Leukemia (01-02-2014)“…We previously identified autoantibodies to the endocytic-associated protein Huntingtin-interacting protein 1-related (HIP1R) in diffuse large B-cell lymphoma…”
Get full text
Journal Article -
14
Primary and isolated anaplastic large cell lymphoma of the bone marrow
Published in Leukemia & lymphoma (01-03-2005)“…Anaplastic large cell lymphoma (ALCL) is a T-cell lymphoma in which the majority of patients present with advanced stage III or IV disease. Here we report a…”
Get full text
Journal Article -
15
PASD1, a DLBCL-associated cancer testis antigen and candidate for lymphoma immunotherapy
Published in Leukemia (01-12-2006)Get full text
Journal Article -
16
Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma
Published in Blood (15-08-2000)“…Oncogenic anaplastic lymphoma kinase (ALK) fusion proteins (nucleophosmin–ALK [NPM-ALK] and other variants) are expressed in many cases of anaplastic…”
Get full text
Journal Article -
17
Detection of t(2;5) in anaplastic large cell lymphoma : Comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue
Published in The American journal of surgical pathology (01-11-1999)“…Anaplastic large cell lymphoma (ALCL) is associated with the t(2;5)(p23;q35) translocation involving the anaplastic lymphoma kinase gene (ALK) and the…”
Get full text
Journal Article -
18
A novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain protein
Published in British journal of cancer (05-07-2004)“…Here we report that the OX-TES-1 SEREX antigen, which showed immunological reactivity with serum from four out of 10 diffuse large B-cell lymphoma (DLBCL)…”
Get full text
Journal Article -
19
Detection of normal and chimeric nucleophosmin in human cells
Published in Blood (15-01-1999)“…In anaplastic large-cell lymphoma (ALCL), the (2;5) chromosomal translocation creates a fusion gene encoding the 80-kD NPM-ALK hybrid protein. This report…”
Get full text
Journal Article -
20
Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins
Published in Histopathology (01-02-2000)“…Aims To analyse the relationship between expression of cytotoxic proteins, histopathology and the CD30 status in primary cutaneous T‐cell disorders, we…”
Get full text
Journal Article